L0060 Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
- 作者N. Dursunoglu; D. Dursunoglu; S. Özkurt; G. Kiter; F. Evyapan
- 卷第8卷
- 印刷ISSN1389-9457
- 文件大小60.31KB
- 发表时间2007
- DOI10.1016/s1389-9457(07)70427-6
P0104 Previous augmentation is not predictive for re-occurrence of augmentation under dopaminergic therapy in severe restless legs syndromeR. Kohnen; H. Benes; B. Högl; C. Trenkwalder · 2007
O0073 Double-blind, multi-centre, 2-year long-term study comparing treatment with cabergoline and levodopa in severe restless legs patientsB. Högl; H. Benes; R. Kohnen; C. Trenkwalder; Caldir Study Group · 2007
Loss of response during long-term treatment of restless legs syndrome: Guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trialsD. Garcia-Borreguero; R. Allen; R. Kohnen; H. Benes; J. Winkelman; B. Högl; L. Ferini-Strambi; M. Zucconi; C. Trenkwalder · 2010
1.299 Head-to-head comparison of transdermal lisuride and oral ropinirole in Restless Legs Syndrome: Results from the first placebo- and active-controlled, double-blind, randomized, 12-week efficacy trialH. Benes; B. Högl; C. Trenkwalder; K. Stiasny-Kolster; D. Palla; R. Kohnen · 2007